ID SUV91_BOVIN Reviewed; 412 AA.
AC Q2NL30;
DT 03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT 07-FEB-2006, sequence version 1.
DT 04-NOV-2026, entry version 120.
DE RecName: Full=Histone-lysine N-methyltransferase SUV39H1;
DE EC=2.1.1.- {ECO:0000250|UniProtKB:O43463};
DE AltName: Full=Suppressor of variegation 3-9 homolog 1;
DE Short=Su(var)3-9 homolog 1;
GN Name=SUV39H1;
OS Bos taurus (Bovine).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC Bovinae; Bos.
OX NCBI_TaxID=9913;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=Crossbred X Angus; TISSUE=Liver;
RG NIH - Mammalian Gene Collection (MGC) project;
RL Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Histone methyltransferase that specifically mediates
CC trimethylation of 'Lys-9' of histone H3 (H3K9me3) using monomethylated
CC H3 'Lys-9' (H3K9me1) as substrate. Also weakly methylates histone H1
CC (in vitro). H3 'Lys-9' trimethylation represents a specific tag for
CC epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3
CC and/or CBX5) proteins to methylated histones (By similarity). Mainly
CC functions in heterochromatin regions, thereby playing a central role in
CC the establishment of constitutive heterochromatin at pericentric and
CC telomere regions. H3 'Lys-9' trimethylation is also required to direct
CC DNA methylation at pericentric repeats (By similarity). SUV39H1 is
CC targeted to histone H3 via its interaction with RB1 and is involved in
CC many processes, such as repression of MYOD1-stimulated differentiation,
CC regulation of the control switch for exiting the cell cycle and
CC entering differentiation, repression by the PML-RARA fusion protein,
CC BMP-induced repression, repression of switch recombination to IgA and
CC regulation of telomere length. Involved in the maintenance of H3K9me3
CC mark following DNA replication, when histone marks are diluted: HP1
CC recognizes the preexisting H3K9me3 mark and serves as a platform to
CC recruit SUV39H1 to modify the adjacent newly incorporated histones.
CC Component of the eNoSC (energy-dependent nucleolar silencing) complex,
CC a complex that mediates silencing of rDNA in response to intracellular
CC energy status and acts by recruiting histone-modifying enzymes. The
CC eNoSC complex is able to sense the energy status of cell: upon glucose
CC starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading
CC to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9'
CC (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA
CC locus (By similarity). Recruited by the large PER complex to the E-box
CC elements of the circadian target genes such as PER2 itself or PER1,
CC contributes to the conversion of local chromatin to a heterochromatin-
CC like repressive state through H3 'Lys-9' trimethylation (By
CC similarity). {ECO:0000250|UniProtKB:O43463,
CC ECO:0000250|UniProtKB:O54864}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=N(6)-methyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-methionine
CC = N(6),N(6)-dimethyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-
CC homocysteine + H(+); Xref=Rhea:RHEA:60284, Rhea:RHEA-COMP:15541,
CC Rhea:RHEA-COMP:15542, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856,
CC ChEBI:CHEBI:59789, ChEBI:CHEBI:61929, ChEBI:CHEBI:61976;
CC Evidence={ECO:0000250|UniProtKB:O54864};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60285;
CC Evidence={ECO:0000250|UniProtKB:O54864};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=N(6),N(6)-dimethyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-
CC methionine = N(6),N(6),N(6)-trimethyl-L-lysyl(9)-[histone H3] + S-
CC adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:60288, Rhea:RHEA-
CC COMP:15538, Rhea:RHEA-COMP:15541, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961,
CC ChEBI:CHEBI:61976; Evidence={ECO:0000250|UniProtKB:O54864};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60289;
CC Evidence={ECO:0000250|UniProtKB:O54864};
CC -!- ACTIVITY REGULATION: Inhibited by S-adenosyl-L-homocysteine. Negatively
CC regulated by CCAR2. {ECO:0000250|UniProtKB:O43463}.
CC -!- SUBUNIT: Interacts with H3 and H4 histones. Interacts with GFI1B,
CC DNMT3B, CBX1, CBX4, CCAR2, MBD1, RUNX1, RUNX3, MYOD1, SMAD5 and RB1.
CC Interacts with SBF1 through the SET domain. Interacts with HDAC1 and
CC HDAC2 through the N-terminus and associates with the core histone
CC deacetylase complex composed of HDAC1, HDAC2, RBBP4 and RBBP7.
CC Component of the eNoSC complex, composed of SIRT1, SUV39H1 and RRP8.
CC Interacts (via SET domain) with MECOM; enhances MECOM transcriptional
CC repression activity. Interacts with LMNA; the interaction increases
CC stability of SUV39H1. The large PER complex involved in the histone
CC methylation is composed of at least PER2, CBX3, TRIM28, SUV39H1 and/or
CC SUV39H2; CBX3 mediates the formation of the complex. Interacts with
CC ZNF152; this interaction initiates heterochromatin formation (By
CC similarity). {ECO:0000250|UniProtKB:O43463,
CC ECO:0000250|UniProtKB:O54864}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43463}.
CC Chromosome {ECO:0000250|UniProtKB:O43463}. Nucleus lamina
CC {ECO:0000250|UniProtKB:O43463}. Nucleus, nucleoplasm
CC {ECO:0000250|UniProtKB:O43463}. Chromosome, centromere
CC {ECO:0000250|UniProtKB:O43463}. Note=Associates with centromeric
CC constitutive heterochromatin. Recruited to pericentromeric
CC heterochromatin via its chromo domain, which specifically recognizes
CC and binds histone H3 monoubiquitinated at 'Lys-14' (H3K14ub).
CC {ECO:0000250|UniProtKB:O43463}.
CC -!- DOMAIN: Although the SET domain contains the active site of enzymatic
CC activity, both pre-SET and post-SET domains are required for
CC methyltransferase activity. The SET domain also participates in stable
CC binding to heterochromatin. {ECO:0000250|UniProtKB:O43463}.
CC -!- DOMAIN: In the pre-SET domain, Cys residues bind 3 zinc ions that are
CC arranged in a triangular cluster; some of these Cys residues contribute
CC to the binding of two zinc ions within the cluster.
CC {ECO:0000250|UniProtKB:O43463}.
CC -!- DOMAIN: The chromo domain specifically recognizes and binds histone H3
CC monoubiquitinated at 'Lys-14' (H3K14ub).
CC {ECO:0000250|UniProtKB:O43463}.
CC -!- PTM: Phosphorylated on serine residues, and to a lesser degree, on
CC threonine residues (By similarity). Phosphorylated at Ser-391 by CDK2
CC during S-M phases, impairing localization to heterochromatin (By
CC similarity). {ECO:0000250|UniProtKB:O43463,
CC ECO:0000250|UniProtKB:O54864}.
CC -!- PTM: Acetylated at Lys-266, leading to inhibition of enzyme activity.
CC SIRT1-mediated deacetylation relieves this inhibition (By similarity).
CC {ECO:0000250|UniProtKB:O43463}.
CC -!- PTM: Ubiquitinated by the DCX(DCAF13) E3 ubiquitin ligase complex,
CC leading to its degradation. Ubiquitinated at Lys-138 by the ECS(ASB7)
CC complex, leading to its degradation. {ECO:0000250|UniProtKB:O43463}.
CC -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC superfamily. Histone-lysine methyltransferase family. Suvar3-9
CC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00912}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC111156; AAI11157.1; -; mRNA.
DR RefSeq; NP_001039729.1; NM_001046264.2.
DR AlphaFoldDB; Q2NL30; -.
DR SMR; Q2NL30; -.
DR FunCoup; Q2NL30; 1687.
DR STRING; 9913.ENSBTAP00000006178; -.
DR PaxDb; 9913-ENSBTAP00000006178; -.
DR GeneID; 523047; -.
DR KEGG; bta:523047; -.
DR CTD; 6839; -.
DR eggNOG; KOG1082; Eukaryota.
DR InParanoid; Q2NL30; -.
DR OMA; ACDETCD; -.
DR OrthoDB; 308383at2759; -.
DR Proteomes; UP000009136; Unplaced.
DR GO; GO:0005677; C:chromatin silencing complex; IEA:UniProtKB-ARBA.
DR GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR GO; GO:0000792; C:heterochromatin; ISS:UniProtKB.
DR GO; GO:0005652; C:nuclear lamina; ISS:UniProtKB.
DR GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR GO; GO:0005721; C:pericentric heterochromatin; ISS:UniProtKB.
DR GO; GO:0140258; F:histone H3K14ub reader activity; ISS:UniProtKB.
DR GO; GO:0046974; F:histone H3K9 methyltransferase activity; ISS:UniProtKB.
DR GO; GO:0140947; F:histone H3K9me2 methyltransferase activity; ISS:UniProtKB.
DR GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR GO; GO:0031507; P:heterochromatin formation; ISS:UniProtKB.
DR GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR GO; GO:0031508; P:pericentric heterochromatin formation; ISS:UniProtKB.
DR CDD; cd18639; CD_SUV39H1_like; 1.
DR CDD; cd10525; SET_SUV39H1; 1.
DR FunFam; 2.170.270.10:FF:000008; Histone-lysine N-methyltransferase; 1.
DR FunFam; 2.40.50.40:FF:000015; Histone-lysine N-methyltransferase; 1.
DR Gene3D; 2.40.50.40; -; 1.
DR Gene3D; 2.170.270.10; SET domain; 1.
DR InterPro; IPR016197; Chromo-like_dom_sf.
DR InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR InterPro; IPR023780; Chromo_domain.
DR InterPro; IPR023779; Chromodomain_CS.
DR InterPro; IPR011381; H3-K9_MeTrfase_SUV39H1/2-like.
DR InterPro; IPR050973; H3K9_Histone-Lys_N-MTase.
DR InterPro; IPR003616; Post-SET_dom.
DR InterPro; IPR007728; Pre-SET_dom.
DR InterPro; IPR001214; SET_dom.
DR InterPro; IPR046341; SET_dom_sf.
DR PANTHER; PTHR46223; HISTONE-LYSINE N-METHYLTRANSFERASE SUV39H; 1.
DR PANTHER; PTHR46223:SF1; HISTONE-LYSINE N-METHYLTRANSFERASE SUV39H1; 1.
DR Pfam; PF00385; Chromo; 1.
DR Pfam; PF05033; Pre-SET; 1.
DR Pfam; PF00856; SET; 1.
DR PIRSF; PIRSF009343; SUV39_SET; 1.
DR SMART; SM00298; CHROMO; 1.
DR SMART; SM00508; PostSET; 1.
DR SMART; SM00468; PreSET; 1.
DR SMART; SM00317; SET; 1.
DR SUPFAM; SSF54160; Chromo domain-like; 1.
DR SUPFAM; SSF82199; SET domain; 1.
DR PROSITE; PS00598; CHROMO_1; 1.
DR PROSITE; PS50013; CHROMO_2; 1.
DR PROSITE; PS50868; POST_SET; 1.
DR PROSITE; PS50867; PRE_SET; 1.
DR PROSITE; PS51579; SAM_MT43_SUVAR39_3; 1.
DR PROSITE; PS50280; SET; 1.
PE 2: Evidence at transcript level;
KW Acetylation; Biological rhythms; Cell cycle; Centromere;
KW Chromatin regulator; Chromosome; Differentiation; Isopeptide bond;
KW Metal-binding; Methyltransferase; Nucleus; Phosphoprotein;
KW Reference proteome; Repressor; rRNA processing; S-adenosyl-L-methionine;
KW Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW Zinc.
FT CHAIN 1..412
FT /note="Histone-lysine N-methyltransferase SUV39H1"
FT /id="PRO_0000281809"
FT DOMAIN 43..101
FT /note="Chromo"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT DOMAIN 179..240
FT /note="Pre-SET"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00157"
FT DOMAIN 243..366
FT /note="SET"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT DOMAIN 396..412
FT /note="Post-SET"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT REGION 1..89
FT /note="Interaction with SIRT1"
FT /evidence="ECO:0000250|UniProtKB:O43463"
FT REGION 255..377
FT /note="Mediates interaction with MECOM"
FT /evidence="ECO:0000250|UniProtKB:O54864"
FT BINDING 181
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 181
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 183
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 186
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 186
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 194
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 195
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 195
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 222
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 222
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 226
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 228
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 232
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 254..256
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 297
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT BINDING 323..324
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 326
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="4"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 400
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="4"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 402
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="4"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT BINDING 407
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_label="4"
FT /evidence="ECO:0000250|UniProtKB:Q9H5I1"
FT MOD_RES 266
FT /note="N6-acetyllysine"
FT /evidence="ECO:0000250|UniProtKB:O43463"
FT MOD_RES 391
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43463"
FT CROSSLNK 138
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in ubiquitin)"
FT /evidence="ECO:0000250|UniProtKB:O43463"
SQ SEQUENCE 412 AA; 47846 MW; 723990F42CDFAFC2 CRC64;
MAESLKGCSV CCKSSWNQLQ DLCRLAKLSC PALGISKRNL YDFEVEYLCD YKKIREQEYY
LVKWRGYPDS ESTWEPRQNL KCVRILKQFH KDLERELLRR HHRSKPPRHL DPSLANYLVQ
KAKQRRALRR WEQELNAKRS HLGRITVENE VDLDGPPRAF VYINEYRVGE GITLNQVAVG
CECQDCLWAP AGGCCPGASL HKFAYNDQGQ VRLRAGLPIY ECNSRCRCGY DCPNRVVQKG
IRYDLCIFRT DDGRGWGVRT LEKIRKNSFV MEYVGEIITS EEAERRGQIY DRQGATYLFD
LDYVEDVYTV DAAYYGNISH FVNHSCDPNL QVYNVFIDNL DERLPRIAFF ATRTIRAGEE
LTFDYNMQVD PVDMESTRMD SNFGLAGLPG SPKKRVRIEC KCGTESCRKY LF
//